KYTHERA Biopharmaceuticals to Present at Lazard Capital Markets 9th Annual Healthcare Conference

LOS ANGELES--(BUSINESS WIRE)--

KYTHERA Biopharmaceuticals, Inc. KYTH today announced that Keith Leonard, President and Chief Executive Officer, will present a corporate overview at the Lazard Capital Markets 9th Annual Healthcare Conference in New York City.

Event: Lazard Capital Markets 9th Annual Healthcare Conference, New York City
Date: Wednesday, November 14, 2012
Time: 9:00 a.m. ET

A live webcast will be available on the Company's website at www.kytherabiopharma.com under the Investors section. The presentation will be archived on the website and will be available for 14 days.

About KYTHERA Biopharmaceuticals, Inc.

KYTHERA Biopharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel prescription products for the aesthetic medicine market. KYTHERA's product candidate, ATX-101, is a potential first-in-class, injectable treatment currently in Phase III clinical development for the reduction of submental fat, which commonly presents as an undesirable “double chin.” KYTHERA also maintains an active research interest in hair and fat biology, pigmentation modulation and facial contouring. Find more information at http://www.kytherabiopharma.com.